Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 2.50 MYR
Change Today -0.05 / -1.96%
Volume 55.4K
YSP On Other Exchanges
Symbol
Exchange
Kuala Lumpur
As of 11:32 PM 07/5/15 All times are local (Market data is delayed by at least 15 minutes).

y.s.p.southeast asia holding (YSP) Snapshot

Open
2.50
Previous Close
2.55
Day High
2.50
Day Low
2.47
52 Week High
07/1/15 - 2.69
52 Week Low
12/16/14 - 1.19
Market Cap
334.8M
Average Volume 10 Days
1.1M
EPS TTM
0.15
Shares Outstanding
133.9M
EX-Date
07/23/15
P/E TM
16.3x
Dividend
0.07
Dividend Yield
2.60%
Current Stock Chart for Y.S.P.SOUTHEAST ASIA HOLDING (YSP)

Related News

No related news articles were found.

y.s.p.southeast asia holding (YSP) Related Businessweek News

No Related Businessweek News Found

y.s.p.southeast asia holding (YSP) Details

Y.S.P. Southeast Asia Holding Berhad, an investment holding company, manufactures, imports, exports, and trades in various kinds of pharmaceutical products. The company offers its products in gels, capsules, tablets, suppositories, creams, syrups, suspensions, and powder dosage forms. It provides prescription products comprising antibacterial and analgesic lozenges, antibiotics, antidiarrheals, antiemetics, antihistamines, antihistamine plus decongestant, antiprotozoal and antiamoebic, antispasmodics, antispasmodics with psycholeptics, drugs for gout therapy, H2-antagonists, antifibrinolytics, nootropics and neurotonics, non-steroidal anti-inflammatory, antipyretics and analgesics, peripheral vasodilators, proton pump inhibitors, and skeletal muscle relaxants; antiasthmatic, anti-diabetic, antifungal, lipid regulating, antihypertensive, antitussive, antiviral, and chemotherapeutics agents, as well as and steroidal, anorectal, and topical preparations. The company also offers non-prescription products, such as anthelmintic agents, antacids, anti-inflammatory enzymes, antipyretics and analgesics, anti-platelet, carminatives, digestive enzymes, expectorants/mucolytic agents, haemorrhoidal, laxatives, and topical preparations; and traditional medicines. In addition, it provides veterinary pharmaceutical products for aquatic and live stock, including anthelmintics, antibiotics, antifungals, anticoccidial agent, antipyretics and analgesics, disinfectants, electrolytes, hematopoietic nutrients, herbal extracts, hormones preparations, probiotics, immune enhancers, vitamins and minerals supplements, antimicrobial, larval feeds, and minerals. Further, the company offers disposables, medical devices, test kits, first aids, medical aids, and insect repellents. It operates in Malaysia, Singapore, the Philippines, Vietnam, Cambodia, Myanmar, Brunei, and other countries. The company was founded in 1987 and is headquartered in Kuala Lumpur, Malaysia.

Founded in 1987

y.s.p.southeast asia holding (YSP) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

y.s.p.southeast asia holding (YSP) Key Developments

Y.S.P. Southeast Asia Holding Berhad Announces First and Final Single Tier Dividend, Payable on August 25, 2015

Y.S.P. Southeast Asia Holding Berhad announced first and final single tier dividend of 6.5 sen per ordinary share of MYR 1.00 each, payable on August 25, 2015. The company announced ex-dividend date as July 23, 2015.

Y.S.P. Southeast Asia Holding Berhad Announces Audited Company Earnings Results for the Year Ended December 31, 2014

Y.S.P. Southeast Asia Holding Berhad announced audited company earnings results for the year ended December 31, 2014. For the year, the company’s revenue was MYR 10,543,000 against MYR 12,425,000 a year ago. Results from operating activities were MYR 10,427,000 against MYR 11,333,000 a year ago. Profit before tax was MYR 12,496,000 against MYR 13,312,000 a year ago. Profit attributable to owners of the company was MYR 12,359,000 against MYR 11,737,000 a year ago. Net cash used in operating activities was MYR 844,000 against MYR 784,000 a year ago.

Y.S.P. Southeast Asia Holding Berhad, Annual General Meeting, Jun 29, 2015

Y.S.P. Southeast Asia Holding Berhad, Annual General Meeting, Jun 29, 2015., at 09:30 Singapore Standard Time. Location: at the Putrajaya Ballroom 1, Level 3, Putrajaya Marriott Hotel. Agenda: To receive the Audited Financial Statements of the company and its Group for the financial year ended 31st December 2014; to approve the payment of directors' fees; to approve the payment of first and final single tier dividend of 6.5 sen per ordinary share of MYR 1.00 each for the financial year ended 31st December 2014; to re-elect director; to re-appoint KPMG as Auditors; to consider retention of independent directors; to issue shares pursuant to Section 132D of the Companies Act, 1965; to propose shareholders' mandate for recurrent related party transactions of a revenue or trading nature for RRPT 1 to RRPT 8 and RRPT 10, 9, 11; and to transact any other business which may properly be transacted at an Annual General Meeting for which due notice shall have been given.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
YSP:MK 2.50 MYR -0.05

YSP Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for YSP.
View Industry Companies
 

Industry Analysis

YSP

Industry Average

Valuation YSP Industry Range
Price/Earnings 16.4x
Price/Sales 1.6x
Price/Book 1.4x
Price/Cash Flow 16.4x
TEV/Sales 1.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Y.S.P.SOUTHEAST ASIA HOLDING, please visit www.yspsah.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.